SLC5A2 and chronic kidney disease: Other studies (39, 40, 43, 71–73), however, including our own recently published study (33), suggest that SGLT2 inhibition additionally ameliorates renal fibrosis in CKD rats by limiting macrophage differentiation and reducing infiltration of inflammatory cells and local expression of inflammatory factors.